Pricing strategies, executive committee power and negotiation leverage in New Zealand’s containment of public spending on pharmaceuticals
(2022)
Journal Article
Main, B., Csanadi, M., & Ozieranski, P. (2022). Pricing strategies, executive committee power and negotiation leverage in New Zealand’s containment of public spending on pharmaceuticals. Health Economics, Policy and Law, 17(3), 348-365. https://doi.org/10.1017/s1744133122000068
This paper explores policy mechanisms behind New Zealand’s remarkable track record of cost containment in public pharmaceutical spending, contrasting with most other advanced economies. We drew on a review of official policy documents and 28 semi-str... Read More about Pricing strategies, executive committee power and negotiation leverage in New Zealand’s containment of public spending on pharmaceuticals.